Spike GP 77–85 (HLA-A*02:01) LLLNCLWSV
€210.00*
Prices excl. VAT plus shipping
costs
Available, delivery time:
3 weeks
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity:
95% HPLC-MS
Caution:
For research use only. Not for use in humans.
Amount in mg
1
Product number: EP11419_5
Description
LLLNCLWSV is a linear peptidic epitope (epitope ID37536) studied as part of Spike glycoprotein from Human coronavirus 229E and Spike glycoprotein from Severe acute respiratory syndrome-related coronavirus. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assay
TechData
| Sequence: | LLLNCLWSV |
| Gene: | S |
| Delivery: | 3 weeks |
| C-Terminus: | OH |
| N-Terminus: | H |
| Amount: | 1 mg |
| Counterion: | TFA |
| Protein: | Spike glycoprotein |
| Allele: | HLA-A*02:01 |
| Application: | Flow Cytometry, Immunohistochemistry |
| Purity: | 95% HPLC-MS |